EME
Energy Metals Ltd
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Energy Metals Ltd. is an Australian uranium exploration company. The company is headquartered in Perth, Western Australia. The company went IPO on 2005-09-09. The firm is focused on exploration and development of a portfolio of projects located in the Northern Territory and Western Australia. The firm has eight projects covering an area of 2,400 square kilometers (km2). Its projects include Bigrlyi, Ngalia regional, Macallan, Anketell, Mopoke Well, Lakeside, Manyingee and Lake Mason. The Bigrlyi deposit is a sandstone hosted uranium-vanadium deposit located on the northern margin of the Ngalia Basin, approximately 350 kilometer (km) northwest of Alice Springs. The Ngalia Regional project is located in the Ngalia Basin, between 180 and 350 km northwest of Alice Springs in the Northern Territory. The Macallan project comprises single exploration license application (ELA27333), located approximately 460 km northwest of Alice Springs and 140 km from Bigrlyi. The Anketell project is located approximately 100 km east of Mt Magnet and comprises retention license R58/2.
📈 Performance
Price History
-68.73%
1M
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.10
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in EME
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in EME
N/A
EME investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in EME also invest in...
Want more shares? Try these...
European Metals Holdings Ltd. engages in the development of the Cinovec lithium and tin project. The company is headquartered in Perth, Western Australia. The company went IPO on 2012-07-19. The firm focused on advancing the Cinovec vertically integrated battery metals project in Czech Republic. The Company, through its subsidiary, Geomet s.r.o., controls the mineral exploration licenses over the Cinovec Lithium/Tin project. Cinovec hosts a global hard rock lithium deposit with a total indicated mineral resource of 372.4 Mt. The project is located approximately 100 kilometers northwest from Prague on the border with Germany, adjacent to a main road with two rail lines within 10 kilometers of the deposit. The project is situated in the heart of Europe with ready access to end user car makers and companies involved in energy storage.
📊 Share price
$0.58 AUD
Emyria Ltd. is a healthcare technology and services company. The company is headquartered in Leederville, Western Australia. The company went IPO on 2020-02-12. The firm is focused on accelerating drug development and improving patient outcomes in neuroscience and mental health through its drug development, new drug discovery, and proprietary real-world data (RWD). The company applies in-house drug development expertise, and proprietary real-world evidence (RWE) gathered from its clinical service, to accelerate the development and registration of two biopharmaceutical drug classes: Ultra-Pure cannabidiol-based medical treatments (CBMTs) and MDMA (ecstasy) analogues. Its CBMT development program leverages the proprietary RWE to identify specific dose responses, for specific indications, in specific patient populations. Its EMD-RX5 is a novel, capsule formulation of Ultra-Pure, synthetic cannabidiol to support its registration as an over-the-counter treatment for mild stress and anxiety in patients with chronic pain. The company is also advancing Ultra-Pure CBD (EMD-RX7).
📊 Share price